About us

Message from our President

New possibilities born from flexible thinking

The environment surrounding pharmaceutical companies is changing rapidly.
While interest in the advancement of innovative medical technology is growing due to the heightened awareness of people's health, expectations are rising for medical care that everyone can receive with peace of mind in a society where the birthrate is declining and the population is aging.
In Japan, while curbing the growth of soaring medical and drug costs, reforms to create a sustainable future are underway. In addition, many people in emerging countries, including the Asian region, are seeking safe and high-quality pharmaceuticals.
At Kokando Pharmaceutical, we place the utmost importance on creating high-quality, heartfelt products that patients can use with peace of mind, based on solid knowledge and experience.
We will contribute to people's health by always looking ahead of the times and engaging in research and development with a young mind and taking on new challenges.
Therefore, based on our management philosophy, we will actively invest in research and development, production facilities, and human resource development. Utilizing DX, we strive to develop and produce pharmaceuticals with excellent quality and safety for patients with high ethical and moral standards.

What is required of generic manufacturers.
These are stable supply, quality assurance, reliable information provision, and the expansion of generic drugs to the world.
With the advent of aging societies not only in developed countries but also in emerging countries, drug prices will be restrained, and the overseas market for generic drugs will grow significantly.
At Kokando Pharmaceutical, we promote efficiency through thorough quality control and strict manufacturing control, and provide patients with safe, high-quality products at affordable prices.
In addition to maintaining and improving the quality assurance system established based on the quality manual, we conduct thorough quality control at all stages, from raw materials to final products, with a high level of control awareness regarding the established manufacturing and quality standards.
At Kokando Pharmaceutical, we have introduced state-of-the-art manufacturing equipment to improve productivity, while promoting the computerization of manufacturing processes and the standardization of related human work to produce safe, high-quality products. I am producing.

"Healthier and more beautiful" That's our mission!!

we hope to be of service to people's health and lives by accurately grasping the wishes of people that never change and the new needs that arise with the times.
With ambition and passion, we strive to improve our technical capabilities with flexible thinking, and we will do our best to be of use to everyone.
In addition to the domestic market, we will also expand into overseas markets, mainly in Southeast Asia, with OTC drugs and generic drugs as our pillars.
We appreciate your continued understanding and support.

President COO FUJIWARA Hiroaki

Company Profile

Company Name Kokando Pharmaceutical Co., Ltd.
Established Date February 1st, 1980
Locations Head Office 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
R&D Site 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
Tokyo Office 1-7-1 Yurakucho, Chiyoda-ku, Tokyo, Japan 100-0006
Amagasaki plant 2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803
Sanda plant 21-1 Techno-park, Sanda, Hyogo, Japan 669-1339
Chairman CEO
President COO
FUJIWARA Kunio
FUJIWARA Hiroaki
Capita l 350 Million Yen
Sales Proceeds Sales 7474 Million Yen (for the year ended in June 2023)
Business Outline Manufacturing and Sales of Medicines
Number of Employees 232 (as of June 30, 2023)
Affiliated Companies Kokando Medicine Co., Ltd.
Head office 1-1-1 Yurakucyo,Chiyoda-Ku,Tokyo,Japan 100-0006
Tokyo・Nagoya・Amagasaki

沿革 : History

                                                                                                                                                                                                                              
1980 Company founded
1981 "REISHI", as health food containing activated
1982 Manufacturing site in Amagasaki completed
1983 Manufacturing and marketing of pharmaceutical drugs started
1985 Tokyo Office opened
1986 "SENNA Tablets" launched
1989 "NEO CALCIUM Tablets" launched
1991 "BEAULUCK", for constipation, launched
1992 "NATURAL VITAMIN E" and "VITAMIN C Tablets" launched
1993 The second manufacturing site in Amagasaki relocated (merged later)
1994 "VITAMIN BB" launched
1996 "KOKANDO BENPIYAKU", for constipation, and "NEO VITAMIN EX" launched
1997 The first manufacturing site in Amagasaki expanded and merged as Amagasaki Plant
1998 "VITAMIN EC-L Tablets" launched
2000 Nagoya Office opened
"SOUGOUKANBOUYAKU", a cold remedy, launched
2002 "NEOVITA C Tablets" launched
2003 Several pharmaceutical drugs (analgesics etc.) launched
"CONDRO POWER EX Tablets", for arthralgia, and "BIENYAKU", for Rhinitis, launched
2007 Manufacturing site in Sanda completed
"NEOVITA WHITE PLUS" launched
2008 Head office relocated
2009 "NEW NEOVITAMIN EX", "VITAMIN BB PLUS" and "ADAM A Tablets", an antipyretic analgesic, launched
2010 "RIPOSMIN", for insomnia, launched
2011 "NORIMONOYOINOKUSURI", for motion sickness, launched
2012 "JIYOUKYOUSOUYAKU α", as health food for nourishment and tonicity, launched
Tokyo Office relocated
2013 "FAMOTIDINE Tablets" lanched
2014 "LOXOPROFEN Tablets" lanched
2016 "ALLERBI" lanched
2017 "HEPAFIT" lanched
2018 "NEOVITA WHITE C PLUS" lanched
2021 "ACETAMINOPHEN Tablets" lanched
2023 "Shakuyakukanzoto Extract granules" lanched

事業所 : Office

Head Office

2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803


View larger map

Amagasaki plant

2-8-27, Nagasuhondori, Amagasaki, Hyogo, Japan 660-0803

Sanda plant

21-1 Techno-park, Sanda, Hyogo, Japan 669-1339